Drug Profile
Latrepirdine
Alternative Names: BRN-0622478; Dimebolin; Dimebon; PF-01913539; PF-1913539Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Medivation
- Class Antidementias; Indoles; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors; Butyrylcholinesterase inhibitors; Mitochondrial permeability transition pore modulators; Neuron stimulants; NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Huntington's disease